Literature DB >> 22775520

A clinical knowledge measurement tool to assess the ability of community pharmacists to detect drug-related problems.

Mackenzie Williams1, Gregory M Peterson, Peter C Tenni, Ivan K Bindoff.   

Abstract

INTRODUCTION: Drug-related problems (DRPs) are associated with significant morbidity and mortality, with most DRPs thought to be preventable. Community pharmacists can detect and either prevent or resolve many of these DRPs. A survey-based clinical knowledge measurement tool was designed and validated to estimate a community pharmacist's clinical knowledge and ability to detect and appropriately resolve DRPs.
METHODS: Nine clinical cases with seven multiple-choice statements (63 statements in total) were constructed, based on scenarios that were found to occur frequently in Australian community pharmacies. The statements aimed to assess a pharmacist's ability to identify, gather relevant information about and make appropriate recommendations to resolve, a DRP. The survey was pilot tested with 18 academics at three Australian pharmacy schools, resulting in the removal of 23 statements. The survey was then administered to undergraduate pharmacy students (28 fourth-year, 41 third-year and 42 first-year students) and to 433 Australian community pharmacists who were participating in an intervention documentation trial. The pharmacists' resultant survey scores were correlated against their actual rate of documenting clinical interventions.
RESULTS: The tool had relatively good internal consistency. Significant differences were seen between the three groups of students (P < 0.01). Community pharmacists with additional clinical qualifications had a significantly higher score than other participating pharmacists (P < 0.01). A moderate, but significant, correlation was seen between the pharmacists' survey score and their clinical intervention rate in practice during the trial (P < 0.01).
CONCLUSION: The clinical knowledge measurement tool appeared to estimate a pharmacist's ability to detect and resolve DRPs within the community pharmacy environment.
© 2012 The Authors. IJPP © 2012 Royal Pharmaceutical Society.

Mesh:

Substances:

Year:  2012        PMID: 22775520     DOI: 10.1111/j.2042-7174.2012.00188.x

Source DB:  PubMed          Journal:  Int J Pharm Pract        ISSN: 0961-7671


  6 in total

1.  Clinical knowledge of community pharmacists in Croatia for detecting drug-related problems.

Authors:  Lovre Zekan; Arijana Mestrovic; Ana Seselja Perisin; Mate Portolan; Nada Jambrek; Silvana Jager; Martina Sepetavc; Darko Modun
Journal:  Int J Clin Pharm       Date:  2017-10-16

2.  Identifying Gaps in Community Pharmacists' Competence in Medication Risk Management in Routine Dispensing.

Authors:  Sonja Kallio; Tiina Eskola; Marja Airaksinen; Marika Pohjanoksa-Mäntylä
Journal:  Innov Pharm       Date:  2021-02-11

3.  Uncontrolled Web-based administration of surveys on factual health-related knowledge: a randomized study of untimed versus timed quizzing.

Authors:  Alexander Domnich; Donatella Panatto; Alessio Signori; Nicola Luigi Bragazzi; Maria Luisa Cristina; Daniela Amicizia; Roberto Gasparini
Journal:  J Med Internet Res       Date:  2015-04-13       Impact factor: 5.428

4.  Drug therapy-related problem management in Nigeria community pharmacy - process evaluation with simulated patient.

Authors:  Showande Johnson Segun; Lawal Sodiq Damilola
Journal:  BMC Health Serv Res       Date:  2022-02-16       Impact factor: 2.655

Review 5.  Mapping the terrain: A conceptual schema for a mental health medication support service in community pharmacy.

Authors:  Shane Scahill; Jane L Fowler; H Laetitia Hattingh; Fiona Kelly; Amanda J Wheeler
Journal:  SAGE Open Med       Date:  2015-09-30

6.  Improving community pharmacists' clinical knowledge to detect and resolve drug-related problems in Croatia: a before/after survey study investigating the efficacy of an educational intervention.

Authors:  Lovre Zekan; Arijana Mestrovic; Ana Seselja Perisin; Josipa Bukic; Dario Leskur; Doris Rusic; Darko Modun
Journal:  BMJ Open       Date:  2020-06-01       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.